CompletedNot Applicable

Study to Investigate the Treatment Benefit of Probiotic Lactobacillus Crispatus M247 in Women Undergoing Homologous Level 2 Assisted Reproductive Technology (ART) Procedures

Italy160 participantsStarted 2020-01-10

Plain-language summary

The present study is aimed to explore the treatment effect from the intake of probiotic Lactobacillus crispatus M247 in the improvement of clinical and psychological aspects in women undergoing homologous level 2 ART procedures.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women undergoing homologous level 2 assisted reproductive technology (ART) procedures * Cryopreserved oocytes * D3 embryos * D5 blastulae * Age 18-45 Exclusion Criteria: * Presence of submucous uterine myomas. * Uterine malformations.

What they're measuring

Pregnancy

Timeframe: up to 12 months

Trial details

NCT IDNCT05871242

SponsorDr. Amjad Khan

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-12-31

View on ClinicalTrials.gov More Fertility Issues trials